Future studies should be encouraged to pin-point the actual cellular and molecular mechanisms of DHX36 function in lung cancer by either activation or overexpression of DHX36, which could be proceeded by either CRISPR-based genomic editing or small molecules predicted by chemical docking simulation. The gene discussed is DHX36; the disease is lung cancer.